Hetero Launches Generic Breast Cancer Treatment Drug Hertab in India

Oncology Division

Share:

11. Jan. 2019

Hetero Launches Generic Breast Cancer Treatment Drug in India

Hetero has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country. The tablets, under the brand name 'Hertab', have been launched in the strength of 250 mg, the product is marketed and distributed by Hetero Healthcare Ltd and has been made available in two stock keeping units (SKUs).The tablets are used in combination with Capecitabine or Letrozole, which together inhibit the growth of cancer cells in patient.

Small Changes make a Big Difference in GERD Management

Tips from Experts on GERD Management

01. Dec. 2020 Read More

Genx Division

Excellence Award for Launch of COVID Drug by Express Pharma

COVID Drug Launch Excellence Award to Hetero Healthcare

Express pharma Excellence award is one of the most prestigious awards for the industry leading pharmaceutical companies. This year’s annual program was conducted on 20th August on E-platform.

20. Aug. 2020 Read More

COVID 19 Management

Hetero Launches Generic COVID-19 Treatment Drug Favipiravir in India under brand name FAVIVIR

After Covifor Injection, Hetero developed the second drug 'Favipiravir' for treatment of mild to moderate Coronavirus symptoms following the approvals from the Drug Controller General of India (DCGI) to manufacture and market the generic drug unde

29. Jul. 2020 Read More

Gastro Division

Remdesivir Reason For Hope In Covid-19 Treatment

Mr. M. Srinivas Reddy, Managing Director of Hetero Healthcare Limited says, Remdesivir Reason For Hope In Covid-19 Treatment.

25. Jun. 2020 Read More

ARV Division

Annual International Reward Ceremony - Singapore

The third Annual International Award Ceremony was celebrated in Singapore by 275 people that included 125 qualifiers and their family members.

07. Feb. 2020 Read More

Genx Division

Certificate of Excellence GOLD Award for ITBOR

Hetero Genx team is proud to receive the "Certificate of Excellence" GOLD Award for ITBOR from AWACS under the new introductions of "ACUTE" category amongst the TOP 21- 50 companies for the year 2019.

15. Nov. 2019 Read More

Genx Division

Ahmednagar Kris Division QTR 3 Residential Meeting

Ahmednagar Team fully charged came for their Residential Meeting at Rainbow Retreat Lonavala on 15th and 16th Nov 2019 Team rejoyed with strategies and QTR 1 and 2 rewards making their bags full and heavy. Night opened with fabulous dance show from all

15. Nov. 2019 Read More

KRIS Division

Pune Kris Division QTR 3 Residential Meeting

Pune Region enjoying QTR 3 Residential meeting at Rainbow Resort Lonavala. On 13th and 14th Nov 2019 Team was fully charged for 2 days wherein day 1 was full of reward earning for QTR 1 & 2 followed by DJ and Gala Dinner. Night was sparkling with Talents

13. Nov. 2019 Read More

KRIS Division

Mumbai Western Kris Division QTR 3 Residential Meeting

Mumbai W Region enjoying QTR 3 Residential meeting at Sai River Resort in Nov 19. Team was fully charged for 2 days wherein day 1 was full of reward earning for QTR 1 & 2 followed by DJ and Gala Dinner. Night was sparkling with Talent show

09. Nov. 2019 Read More

KRIS Division

Corporate Annual Event 2019

Hetero Healthcare celebrates Corporate Annual Event on 2nd Nov 2019 at Shilpakala Vedika, Madhapur.

02. Nov. 2019 Read More

Hetero Healthcare

Hetero Launches Generic Breast Cancer Treatment Drug in India

You Might Also Like

Small Changes make a Big Difference in GERD Management

COVID Drug Launch Excellence Award to Hetero Healthcare

Hetero Launches Generic COVID-19 Treatment Drug Favipiravir in India under brand name FAVIVIR

Remdesivir Reason For Hope In Covid-19 Treatment

Annual International Reward Ceremony - Singapore

Certificate of Excellence GOLD Award for ITBOR

Ahmednagar Kris Division QTR 3 Residential Meeting

Pune Kris Division QTR 3 Residential Meeting

Mumbai Western Kris Division QTR 3 Residential Meeting

Corporate Annual Event 2019

Would you like to share your thoughts?

Comments